Table 2), it is likely that new weight-loss drugs will be marketed in the near-term future Table 1: Novel weight-loss drugs approved in the US Navigation Tips: First column and header row are frozen for easy reference Scroll horizontally and vertically to view all data Hover over rows to highlight them Use compact mode to fit more content Search to quickly find specific drugs Hover over truncated text to see full content Table 2: Late-stage anti-obesity drug development pipeline in the US 4
10.1021/acs.biomac.5c00112 Summary Keywords combined therapy, diabetes, diabetic cardiomyopathy, diabetic nephropathy, Ganoderma lucidum polysaccharides, glycolipid metabolism, oxidative stress Citation Xin Y, Zhang X, Han D, Liang Q, Kong L, Guan Y, Sun H, Liu C, Han Y, Wang X and Wang X (2026) Mechanism of Ganoderma lucidum polysaccharides in the mangement of diabetes and its complications
N Engl J Med 375:311322 Hollander P, Gupta AK, Plodkowski R et al (2013) Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes
All sales are final
Increased Water Intake : Many people feel thirstier when managing diabetes and may drink more water, either naturally or as part of their healthcare providers recommendations
When a significant B12 deficiency is corrected, your bone marrow suddenly starts making large numbers of new red blood cells, and that process pulls potassium out of the blood
